• BMAL1 Phase Separation Orchestrates Circadian Transcriptiona

  2026-05-09

  This study uncovers that BMAL1 forms phase-separated nuclear condensates, serving as dynamic transcriptional hubs essential for robust circadian rhythms. By linking BMAL1's intrinsically disordered region and its phosphorylation state to condensate formation and gene expression timing, the research clarifies a mechanistic layer in circadian regulation.

• Biotin-XX Tyramide Reagent: Precision Cell Surface Labeling

  2026-05-08

  Biotin-XX Tyramide Reagent delivers membrane-impermeant, HRP-catalyzed proximity labeling that transforms cell surface proteomics and high-sensitivity signal amplification. This guide details advanced workflows, troubleshooting, and the latest neurobiology-driven use cases, empowering researchers to achieve robust, low-background detection in challenging tissue systems.

• ABT-888 (Veliparib): Unraveling PARP Inhibition in MSI Tumor

  2026-05-08

  Explore the advanced applications and mechanistic nuances of ABT-888 (Veliparib) as a DNA repair inhibitor in microsatellite instability (MSI) tumor models. This article delivers deeper insight into PARP inhibition, practical assay design, and translational strategies for cancer research.

• WNT5a/GSK3/β-catenin Axis Controls FAP Adipogenesis in Muscl

  2026-05-07

  This study elucidates how the WNT5a/GSK3/β-catenin signaling axis regulates adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). Integration of pharmacological inhibition, single-cell analyses, and transcriptomics identifies key intervention points relevant for limiting pathologic fat infiltration in muscle disease.

• TK1 Expression in Uterine Corpus Endometrial Carcinoma: Insi

  2026-05-07

  This study provides a comprehensive analysis of thymidine kinase 1 (TK1) in uterine corpus endometrial carcinoma (UCEC), demonstrating that elevated TK1 expression correlates with poor prognosis and is linked to cell proliferation and immune infiltration patterns. The findings highlight TK1 as a potential prognostic biomarker and therapeutic target in UCEC, with implications for cell cycle and DNA replication research.

• Ganetespib (STA-9090): Precision Hsp90 Inhibition for Next-G

  2026-05-06

  Explore how Ganetespib (STA-9090), a potent small-molecule Hsp90 inhibitor, enables advanced tumor growth inhibition studies. This article uniquely bridges mechanistic insights with practical assay guidance for cancer research.

• U 46619: Applied Workflows for Platelet and Renal Assays

  2026-05-06

  U 46619 (11,9 epoxymethano-prostaglandin H2) enables highly selective modeling of TP receptor-driven platelet aggregation and renal vascular responses, empowering researchers to dissect complex cardiovascular mechanisms with precision. This article delivers evidence-based workflows, troubleshooting strategies, and applied insights to maximize reproducibility and sensitivity in both platelet and renal assay contexts.

• 2'3'-cGAMP (Sodium Salt): Precision Activation of cGAS-STING

  2026-05-05

  Explore how 2'3'-cGAMP (sodium salt) enables precise dissection of cGAS-STING-mediated neuroinflammation, with unique insights from recent studies. Learn how this high-affinity STING agonist advances immunotherapy research and addresses unmet needs in brain injury models.

• Cefiderocol Activity Against Resistant P. aeruginosa and Aci

  2026-05-05

  This study systematically compares the in vitro efficacy of cefiderocol to β-lactam/β-lactamase inhibitor combinations against European clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp., including those resistant to meropenem and other last-line agents. The findings inform antibiotic selection strategies and resistance mechanism analysis in multidrug-resistant Gram-negative pathogens.

• (S)-(+)-Dimethindene maleate: Use in M2 Muscarinic Antagonis

  2026-05-04

  (S)-(+)-Dimethindene maleate provides a selective, high-purity M2 muscarinic receptor antagonist for research into autonomic regulation, cardiovascular, and respiratory system signaling. It is not suitable for diagnostic or therapeutic use, and its storage and experimental preparation require strict adherence to product specifications to ensure reliability.

• A-769662: AMPK Activator Workflows for Energy Metabolism Res

  2026-05-04

  A-769662 empowers metabolic researchers with precise, reversible AMPK activation, enabling robust dissection of energy metabolism and fatty acid synthesis inhibition. Leverage this tool for advanced autophagy and proteasome studies, with actionable troubleshooting and protocol insights.

• TPPU and the sEH–Nrf2 Pathway: Bridging Redox and Bone Healt

  2026-05-03

  This thought-leadership article unpacks the emerging role of TPPU, a potent soluble epoxide hydrolase inhibitor, in translational research targeting the liver-bone axis, redox imbalance, and inflammatory pain. Grounded in fresh mechanistic findings, it provides actionable guidance for experimental design, discusses the competitive landscape, and outlines future opportunities in chronic inflammation and osteoporosis research.

• Sodium Phosphate Dibasic: Optimizing Biological Assay Buffer

  2026-05-02

  Sodium phosphate dibasic (Na2HPO4) is indispensable as a high-purity pH stabilizer and buffer in aquatic toxicology and molecular biology, enabling reliable, reproducible results even in demanding assays. Leveraging APExBIO’s Na2HPO4 (SKU B7293) transforms complex environmental and protein assay workflows, with practical troubleshooting strategies guided by the latest peer-reviewed evidence.

• Q-VD(OMe)-OPh (SKU A8165): Reliable Caspase Inhibition for A

  2026-05-01

  This article offers scenario-driven, evidence-based guidance for biomedical researchers seeking reproducible caspase inhibition in apoptosis assays. Highlighting SKU A8165 (Q-VD(OMe)-OPh) from APExBIO, it addresses experimental design, assay optimization, and data interpretation challenges, referencing peer-reviewed studies and quantitative performance data.

• PP2A-Regulated Autophagy Drives Candida albicans Biofilm Dru

  2026-05-01

  This study elucidates how protein phosphatase 2A (PP2A) enhances drug resistance in Candida albicans biofilms via autophagy induction through ATG protein phosphorylation. The findings highlight PP2A-autophagy as a regulatory axis in antifungal resistance, offering new targets for therapeutic intervention and experimental modeling.

14954 records 1/997 page Next 12345 下5页 Last page